{
    "eid": "2-s2.0-85131037074",
    "title": "Association study identifies genetic determinants and non-genetic factors on steady-state plasma and therapeutic outcome of galantamine in mixed dementia",
    "cover-date": "2022-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "CYP2D6",
        "Galantamine",
        "Mixed dementia",
        "UGT1A1"
    ],
    "authors": [
        "Thitipon Yaowaluk",
        "Vorapun Senanarong",
        "Chanin Limwongse",
        "Rasda Boonprasert",
        "Duangkamon Bunditvorapoom",
        "Supannee Kaewsutthi",
        "Pornpimol Kijsanayotin"
    ],
    "citedby-count": 0,
    "ref-count": 29,
    "ref-list": [
        "Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer\u2019s disease",
        "Clinical practice with antidementia drugs in a geriatric clinic",
        "Opportunities in pharmacogenomics for the treatment of Alzheimer\u2019s disease",
        "Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors",
        "Combination of multiplex PCR and DHPLC-based strategy for CYP2D6 genotyping scheme in Thais",
        "Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation",
        "Expression of <em>UDP-glucuronosyltransferase 1</em> (<em>UGT1</em>) and glucuronidation activity toward endogenous substances in humanized <em>UGT1</em> mouse",
        "Bilirubin and inflammation in neurodegenerative and other neurological diseases",
        "Development of pyrosequencing method for detection of UGT1A1 polymorphisms in Thai colorectal cancers",
        "Apolipoprotein E and Alzheimer disease: risk, mechanisms, and therapy",
        "Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group",
        "APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer\u2019s disease",
        "Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer\u2019s disease",
        "Diagnosis and treatment of dementia: 2. Diagnosis",
        "Pharmacogenomics in Alzheimer\u2019s disease: a genome-wide association study of response to cholinesterase inhibitors",
        "Galantamine population pharmacokinetics in patients with Alzheimer\u2019s disease: modeling and simulations",
        "Relationship of CYP2D6, CYP3A, POR, and ABCB1 genotypes with galantamine plasma concentrations",
        "Donepezil in Alzheimer\u2019s disease: from conventional trials to pharmacogenetics",
        "The metabolism and excretion of galantamine in rats, dogs, and humans",
        "Gender-related differences in pharmacokinetics and their clinical significance",
        "CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials",
        "Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer\u2019s disease patients",
        "CYP2D6 in the brain: genotype effects on resting brain perfusion",
        "Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry",
        "The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment",
        "Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis",
        "Predictors of long-term cognitive outcome in Alzheimer\u2019s disease",
        "Rate of memory decline in AD is related to education and occupation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Department of Health Research and Development",
        "Siriraj Hospital, Mahidol University",
        "Chulalongkorn University Fund",
        "Srinakharinwirot University"
    ]
}